The Role of Minimally Invasive Devices in Modern Cardiac Care
Valued at USD 22.57 billion in 2025, the U.S. Cardiovascular Device Market is projected to reach USD 24.87 billion in 2026 and USD 38.55 billion by 2034, growing at a CAGR of 5.60% during the forecast period 2026–2034. Leading companies including Abbott Laboratories, Boston Scientific Corporation, Medtronic Plc, Edwards Lifesciences Corporation, Biotronik SE & Co. KG, Terumo...
0 Σχόλια 0 Μοιράστηκε 245 Views 0 Προεπισκόπηση